Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Overview
Financials & Estimates
Ownership
Dividend
Valuation
Income statement
Quarter data

Valuation

 

Novonesis

436.60 DKK-3.11 %4/9 17:01
Less than 1K followers

NSIS B

NASDAQ Copenhagen

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor views
Valuation
Income statement

Valuation

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Novonesis

P/E

Median 2019-2025

EV/S

Median 2019-2025

EV/EBIT

Median 2019-2025

Dividend yield

Median 2019-2025

P/B

Median 2019-2025

 
2019202020212022202320242025
Share price (DKK)326.00349.50537.20351.90371.10407.70407.80
Shares287.6282.0277.9276.6281.0468.3468.3
Market cap93,757.698,559.0149,298.197,335.5104,279.1190,925.4190,972.2
Enterprise value97,806.6102,430.0154,523.1103,142.5110,944.1202,237.3211,361.4
EV/S6.87.310.35.96.27.16.8
EV/EBITDA18.720.828.517.120.720.918.3
EV/EBIT24.228.038.622.627.954.134.7
P/E29.734.947.526.534.081.643.7
P/B8.178.7712.236.847.272.292.36
P/S6.57.010.05.55.86.76.2
Dividend yield1.6 %1.5 %1.0 %1.7 %1.7 %1.0 %1.0 %
Equity ratio56.2 %54.8 %49.3 %50.8 %50.6 %73.6 %66.4 %
Gearing ratio41.8 %41.8 %51.6 %48.1 %54.2 %16.1 %27.7 %